TBCEL
gene geneOn this page
Also known as MGC10233
Summary
TBCEL (tubulin folding cofactor E like, HGNC:28115) is a protein-coding gene on chromosome 11q23.3, encoding Tubulin-specific chaperone cofactor E-like protein (Q5QJ74). Acts as a regulator of tubulin stability.
Predicted to enable alpha-tubulin binding activity. Predicted to be involved in microtubule cytoskeleton organization; post-chaperonin tubulin folding pathway; and tubulin complex assembly. Predicted to be located in cytoskeleton. Predicted to be active in cytoplasm.
Source: NCBI Gene 219899 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 42 total
- MANE Select transcript:
NM_001363644
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:28115 |
| Approved symbol | TBCEL |
| Name | tubulin folding cofactor E like |
| Location | 11q23.3 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | MGC10233 |
| Ensembl gene | ENSG00000154114 |
| Ensembl biotype | protein_coding |
| OMIM | 610451 |
| Entrez | 219899 |
Gene structure
Transcript identifiers
Ensembl transcripts: 25 — 20 protein_coding, 3 nonsense_mediated_decay, 2 retained_intron
ENST00000284259, ENST00000422003, ENST00000524726, ENST00000529397, ENST00000530362, ENST00000531148, ENST00000533134, ENST00000533169, ENST00000533712, ENST00000683345, ENST00000885762, ENST00000885763, ENST00000885764, ENST00000885765, ENST00000885766, ENST00000885767, ENST00000885768, ENST00000885769, ENST00000885770, ENST00000885771, ENST00000923205, ENST00000967565, ENST00000967566, ENST00000967567, ENST00000967568
RefSeq mRNA: 3 — MANE Select: NM_001363644
NM_001130047, NM_001363644, NM_152715
CCDS: CCDS31692
Canonical transcript exons
ENST00000683345 — 9 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001374752 | 121045674 | 121045823 |
| ENSE00001390952 | 121053551 | 121053732 |
| ENSE00002167894 | 121036505 | 121036612 |
| ENSE00002170236 | 121024102 | 121024291 |
| ENSE00003459498 | 121047528 | 121047667 |
| ENSE00003478158 | 121059969 | 121060085 |
| ENSE00003501157 | 121055052 | 121055308 |
| ENSE00003649210 | 121058345 | 121058471 |
| ENSE00003920636 | 121086778 | 121090776 |
Expression profiles
Bgee: expression breadth ubiquitous, 265 present calls, max score 94.51.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 10.4514 / max 91.0908, expressed in 1739 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 117174 | 10.4514 | 1739 |
Top tissues by expression
285 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| secondary oocyte | CL:0000655 | 94.51 | gold quality |
| colonic epithelium | UBERON:0000397 | 91.21 | gold quality |
| buccal mucosa cell | CL:0002336 | 90.55 | gold quality |
| calcaneal tendon | UBERON:0003701 | 89.21 | gold quality |
| trabecular bone tissue | UBERON:0002483 | 88.60 | gold quality |
| adrenal tissue | UBERON:0018303 | 86.77 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 85.19 | gold quality |
| seminal vesicle | UBERON:0000998 | 84.74 | gold quality |
| corpus callosum | UBERON:0002336 | 84.15 | gold quality |
| skin of hip | UBERON:0001554 | 84.07 | gold quality |
| right lung | UBERON:0002167 | 83.69 | gold quality |
| lower lobe of lung | UBERON:0008949 | 83.59 | gold quality |
| tendon | UBERON:0000043 | 83.32 | gold quality |
| visceral pleura | UBERON:0002401 | 83.16 | gold quality |
| cauda epididymis | UBERON:0004360 | 83.10 | gold quality |
| monocyte | CL:0000576 | 83.03 | gold quality |
| mononuclear cell | CL:0000842 | 82.72 | gold quality |
| parietal pleura | UBERON:0002400 | 82.52 | gold quality |
| leukocyte | CL:0000738 | 82.25 | gold quality |
| stromal cell of endometrium | CL:0002255 | 81.88 | gold quality |
| islet of Langerhans | UBERON:0000006 | 81.82 | gold quality |
| pleura | UBERON:0000977 | 81.67 | gold quality |
| caput epididymis | UBERON:0004358 | 81.01 | gold quality |
| ventricular zone | UBERON:0003053 | 81.00 | gold quality |
| gall bladder | UBERON:0002110 | 80.88 | gold quality |
| endometrium | UBERON:0001295 | 80.70 | gold quality |
| ovary | UBERON:0000992 | 80.41 | gold quality |
| upper lobe of lung | UBERON:0008948 | 80.11 | gold quality |
| left ovary | UBERON:0002119 | 79.92 | gold quality |
| bone marrow cell | CL:0002092 | 79.90 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 9.48 |
| E-MTAB-9467 | no | 0.65 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
224 targeting TBCEL, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-3646 | 100.00 | 73.56 | 5283 |
| HSA-MIR-4776-3P | 100.00 | 68.73 | 1340 |
| HSA-MIR-3163 | 100.00 | 77.23 | 8605 |
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-4262 | 100.00 | 73.26 | 3931 |
| HSA-MIR-6833-3P | 100.00 | 70.63 | 3197 |
| HSA-MIR-4768-5P | 100.00 | 69.49 | 2861 |
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-7110-3P | 100.00 | 73.18 | 2486 |
| HSA-MIR-6873-3P | 100.00 | 71.42 | 2626 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-548AW | 99.99 | 72.57 | 3559 |
| HSA-MIR-1184 | 99.99 | 68.19 | 1458 |
| HSA-MIR-181A-5P | 99.99 | 72.96 | 2995 |
| HSA-MIR-181B-5P | 99.99 | 72.97 | 2996 |
| HSA-MIR-181C-5P | 99.99 | 72.95 | 2996 |
| HSA-MIR-181D-5P | 99.99 | 73.04 | 2997 |
| HSA-MIR-513B-5P | 99.99 | 69.96 | 2150 |
| HSA-MIR-186-5P | 99.99 | 70.83 | 3707 |
| HSA-MIR-548P | 99.98 | 72.25 | 3784 |
| HSA-MIR-4803 | 99.98 | 71.99 | 3117 |
| HSA-MIR-12136 | 99.98 | 72.81 | 5713 |
| HSA-MIR-103A-3P | 99.98 | 69.14 | 1595 |
| HSA-MIR-107 | 99.98 | 69.14 | 1595 |
| HSA-MIR-548AA | 99.96 | 70.64 | 3753 |
| HSA-MIR-548AP-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-548T-3P | 99.96 | 70.64 | 3753 |
| HSA-MIR-1468-3P | 99.96 | 72.74 | 3797 |
| HSA-MIR-5688 | 99.96 | 73.23 | 4504 |
| HSA-MIR-495-3P | 99.96 | 72.81 | 4197 |
Literature-anchored findings (GeneRIF, showing 2)
- Leucine rich repeat containing 35 (E-like) is a novel regulator of tubulin stability with overexpression causing depolymerization of microtubules and suppression resulting in an increase in the number of stable microtubules. (PMID:15728251)
- Depletion of Op18 by means of RNA interference increased the susceptibility of tubulin to TBCE or E-like mediated disruption, while overexpressed Op18 exerted a tubulin-protective effect. (PMID:18262179)
Cross-species orthologs
6 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | tbcela | ENSDARG00000002682 |
| danio_rerio | tbcelb | ENSDARG00000019525 |
| mus_musculus | Tbcel | ENSMUSG00000037287 |
| rattus_norvegicus | Tbcel | ENSRNOG00000032364 |
| drosophila_melanogaster | mlt | FBGN0265512 |
| caenorhabditis_elegans | WBGENE00016866 |
Paralogs (1): TBCE (ENSG00000284770)
Protein
Protein identifiers
Tubulin-specific chaperone cofactor E-like protein — Q5QJ74 (reviewed: Q5QJ74)
Alternative names: Leucine-rich repeat-containing protein 35
All UniProt accessions (5): Q5QJ74, B3KNB6, E9PNS0, E9PP54, G3V147
UniProt curated annotations — full annotation on UniProt →
Function. Acts as a regulator of tubulin stability.
Subcellular location. Cytoplasm. Cytoskeleton.
Tissue specificity. Abundantly expressed in testis, but is also present in several tissues at a much lower level.
RefSeq proteins (3): NP_001123519, NP_001350573, NP_689928 (=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR000626 | Ubiquitin-like_dom | Domain |
| IPR029071 | Ubiquitin-like_domsf | Homologous_superfamily |
| IPR032675 | LRR_dom_sf | Homologous_superfamily |
| IPR047991 | TBCEL_Ubl | Domain |
Pfam: PF14560, PF14580
UniProt features (16 total): repeat 7, sequence conflict 3, modified residue 2, domain 2, chain 1, coiled-coil region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q5QJ74-F1 | 90.11 | 0.76 |
Functional residue map
Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.
Post-translational modifications (2): 18, 41
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 156 (showing top):
IVANOVA_HEMATOPOIESIS_MATURE_CELL, GOBP_PROTEIN_MATURATION, GOBP_PROTEIN_FOLDING, DOUGLAS_BMI1_TARGETS_DN, LASTOWSKA_NEUROBLASTOMA_COPY_NUMBER_DN, GOMF_ALPHA_TUBULIN_BINDING, GOMF_CYTOSKELETAL_PROTEIN_BINDING, COULOUARN_TEMPORAL_TGFB1_SIGNATURE_UP, KARLSSON_TGFB1_TARGETS_DN, GOBP_TUBULIN_COMPLEX_ASSEMBLY, GOBP_MICROTUBULE_CYTOSKELETON_ORGANIZATION, LINSLEY_MIR16_TARGETS, CHANGOLKAR_H2AFY_TARGETS_DN, TORCHIA_TARGETS_OF_EWSR1_FLI1_FUSION_UP, STK33_NOMO_UP
GO Biological Process (3): microtubule cytoskeleton organization (GO:0000226), tubulin complex assembly (GO:0007021), post-chaperonin tubulin folding pathway (GO:0007023)
GO Molecular Function (2): alpha-tubulin binding (GO:0043014), protein binding (GO:0005515)
GO Cellular Component (2): cytoplasm (GO:0005737), cytoskeleton (GO:0005856)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cytoskeleton organization | 1 |
| microtubule-based process | 1 |
| protein-containing complex assembly | 1 |
| tubulin complex assembly | 1 |
| tubulin binding | 1 |
| binding | 1 |
| intracellular anatomical structure | 1 |
| cellular anatomical structure | 1 |
| intracellular membraneless organelle | 1 |
Protein interactions and networks
STRING
406 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TBCEL | TBCD | Q9BTW9 | 889 |
| TBCEL | TBCC | Q15814 | 589 |
| TBCEL | TIPRL | O75663 | 570 |
| TBCEL | MITD1 | Q8WV92 | 514 |
| TBCEL | TBCA | O75347 | 512 |
| TBCEL | TBCB | Q99426 | 487 |
| TBCEL | PIP5K1B | P78518 | 479 |
| TBCEL | HEMK1 | Q9Y5R4 | 462 |
| TBCEL | RPP38 | P78345 | 449 |
| TBCEL | BTBD8 | Q5XKL5 | 409 |
| TBCEL | TECTA | O75443 | 397 |
| TBCEL | LHFPL3 | Q86UP9 | 391 |
| TBCEL | CBX3 | Q13185 | 390 |
| TBCEL | A0A2R8Y809 | A0A2R8Y809 | 373 |
| TBCEL | FAM171A1 | Q5VUB5 | 370 |
IntAct
18 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TBCEL | MEOX2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TBCEL | LNX1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| MEOX2 | TBCEL | psi-mi:“MI:0915”(physical association) | 0.560 |
| LNX1 | TBCEL | psi-mi:“MI:0915”(physical association) | 0.560 |
| LBX1 | TBCEL | psi-mi:“MI:0915”(physical association) | 0.560 |
| OTX2 | TBCEL | psi-mi:“MI:0915”(physical association) | 0.560 |
| TBCEL | PLEKHF2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| RRAS | KIN | psi-mi:“MI:0914”(association) | 0.350 |
| DCTN1 | NACA | psi-mi:“MI:2364”(proximity) | 0.270 |
| TBCEL | LBX1 | psi-mi:“MI:0915”(physical association) | 0.000 |
| TBCEL | OTX2 | psi-mi:“MI:0915”(physical association) | 0.000 |
| TBCEL | PLEKHF2 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (15): TBCEL (Two-hybrid), TBCEL (Two-hybrid), TBCEL (Proximity Label-MS), TBCEL (Affinity Capture-RNA), TBCEL (Two-hybrid), OTX2 (Two-hybrid), PLEKHF2 (Two-hybrid), TBCEL (Reconstituted Complex), TBCEL (Affinity Capture-MS), TBCEL (Co-fractionation), TBCEL (Affinity Capture-MS), TBCEL (Affinity Capture-MS), TBCEL (Co-fractionation), TBCEL (Co-fractionation), TBCEL (Affinity Capture-RNA)
ESM2 similar proteins: A0JM56, A0JPI9, A4IHG1, A5PK13, D3YY91, F1ND48, O35125, Q13309, Q15813, Q24K06, Q32KP2, Q32KS0, Q32L08, Q32NT4, Q3KQF4, Q3KRC6, Q3UGP9, Q498T9, Q4U2V3, Q5BKY1, Q5DU41, Q5FVQ9, Q5PQJ7, Q5QJ74, Q5R8X9, Q5RBD9, Q5U378, Q66JT1, Q68F79, Q6GQN5, Q6NSJ5, Q6NU09, Q6P9F7, Q6WRX3, Q6ZNQ3, Q8C5W3, Q8CDN9, Q8CIV8, Q8IY45, Q8IZ02
Diamond homologs: H2KYZ5, Q5QJ74, Q5PQJ7, Q8C5W3, Q8GRL7, Q9USX8, Q9XHH2, Q5BGW9, Q5U378, Q9V4Q8, A5A779, P09661, P43333, P57784, Q08963, Q1X8D7, Q4P5F9, Q4R8Y8, Q4WV66, Q5A449, Q5EA80, Q6BT60, Q6C417, Q6YSF3, Q7S9P4, Q8CDN9, Q92696, Q9BLB6, A0A096MJZ0, Q05A62, Q28G94, Q2KID4, Q4LDG9, Q641R9, Q6DHB1, Q84WJ9, Q8T888
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
42 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 33 |
| Likely benign | 1 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1416 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 11:121045404:TTGG:T | donor_gain | 1.0000 |
| 11:121045407:G:GT | donor_gain | 1.0000 |
| 11:121045672:A:AG | acceptor_gain | 1.0000 |
| 11:121045672:AG:A | acceptor_loss | 1.0000 |
| 11:121045673:G:A | acceptor_loss | 1.0000 |
| 11:121045673:G:GA | acceptor_gain | 1.0000 |
| 11:121045673:GC:G | acceptor_gain | 1.0000 |
| 11:121045673:GCA:G | acceptor_gain | 1.0000 |
| 11:121045673:GCAT:G | acceptor_gain | 1.0000 |
| 11:121045673:GCATT:G | acceptor_gain | 1.0000 |
| 11:121045821:AAGG:A | donor_loss | 1.0000 |
| 11:121045823:GGTA:G | donor_loss | 1.0000 |
| 11:121045824:GT:G | donor_loss | 1.0000 |
| 11:121045825:T:G | donor_loss | 1.0000 |
| 11:121047519:A:AG | acceptor_gain | 1.0000 |
| 11:121047520:T:G | acceptor_gain | 1.0000 |
| 11:121047522:A:AG | acceptor_gain | 1.0000 |
| 11:121047523:T:G | acceptor_gain | 1.0000 |
| 11:121047523:TTCA:T | acceptor_loss | 1.0000 |
| 11:121047524:TCAG:T | acceptor_loss | 1.0000 |
| 11:121047525:CA:C | acceptor_loss | 1.0000 |
| 11:121047526:A:AC | acceptor_loss | 1.0000 |
| 11:121047526:A:AG | acceptor_gain | 1.0000 |
| 11:121047526:AGATC:A | acceptor_gain | 1.0000 |
| 11:121047527:G:GA | acceptor_gain | 1.0000 |
| 11:121047527:GAT:G | acceptor_gain | 1.0000 |
| 11:121047527:GATC:G | acceptor_gain | 1.0000 |
| 11:121047527:GATCG:G | acceptor_gain | 1.0000 |
| 11:121047663:ATGAG:A | donor_loss | 1.0000 |
| 11:121047664:TGAGG:T | donor_loss | 1.0000 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000025049 (11:121075883 A>G), RS1000049066 (11:121033968 A>G), RS1000072174 (11:121031332 G>A), RS1000083220 (11:121056881 T>G), RS1000275535 (11:121052184 T>C), RS1000295300 (11:121060610 C>T), RS1000380213 (11:121090224 A>G), RS1000397335 (11:121033661 C>T), RS1000448968 (11:121037623 G>A), RS1000524479 (11:121026572 C>CTT), RS1000535418 (11:121081152 G>A), RS1000541126 (11:121069130 C>T), RS1000616167 (11:121066388 T>C), RS1000655110 (11:121028813 G>T), RS1000657615 (11:121073792 A>G)
Disease associations
OMIM: gene MIM:610451 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
24 total (human), top 24 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Air Pollutants | affects expression, increases abundance, decreases expression | 2 |
| bisphenol F | affects cotreatment, increases expression | 1 |
| dicrotophos | decreases expression | 1 |
| methylmercuric chloride | decreases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| arsenite | increases methylation | 1 |
| sodium arsenite | decreases expression | 1 |
| CGP 52608 | increases reaction, affects binding | 1 |
| jinfukang | decreases expression | 1 |
| Fulvestrant | increases methylation | 1 |
| Leflunomide | increases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Dexamethasone | affects cotreatment, increases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Formaldehyde | increases expression | 1 |
| Indomethacin | increases expression, affects cotreatment | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Ozone | affects expression, increases abundance | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| 1-Methyl-3-isobutylxanthine | affects cotreatment, increases expression | 1 |
| Cyclosporine | decreases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
| Copper Sulfate | decreases expression | 1 |
| Particulate Matter | decreases expression, increases abundance | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.